Ing Investment Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ing Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $22M 18M 1.19
2024-06-30 $16M 15M 1.11
2023-09-30 $14M 15M 0.94

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Wells Fargo Perp Pfd Cnv A (WFC.PL)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Ing Investment Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Camden Asset Management
Lazard Asset Management
Millennium Management
MacKay Shields
Advent Capital Management
Calamos Advisors
Citadel Advisors
Wolverine Asset Management
Bank Of Montreal
Glazer Capital
State Street Corporation
CNH Partners
DeepCurrents Investment Group
BlackRock

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1